EurekAlert!

Enbrel(R) is first therapy shown to inhibit bone and joint damage in PsA

THOUSAND OAKS, Calif., and RADNOR, Penn., – Results from a study of ENBREL® (etanercept), the only fully human TNF receptor, were presented demonstrating significant inhibition in the progression of ...
FierceBiotech

Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis | Fierce Biotech

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...
EurekAlert!

Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data

THOUSAND OAKS, Calif., November 12, 2006 -- Amgen (NASDAQ: AMGN) today announced that Enbrel? (etanercept) is the first biologic with published data to show improvements in multiple measures of ...
PMLiVE

Novartis’ psoriasis drug set to challenge Amgen/Pfizer’s Enbrel

Novartis has posted positive results for its investigational psoriasis treatment secukinumab that demonstrate its superior efficacy to Amgen and Pfizer’s dominant Enbrel. According to data from the ...
Nasdaq

Amgen's Enbrel Patents to Be Upheld Through 2029

Americans with psoriasis and rheumatoid arthritis will have to wait much longer for low-priced copycat versions of their weekly Enbrel injections. Amgen (NASDAQ: AMGN) won an appeals court ruling on ...
MM&M

Enbrel reps risk layoff, as Pfizer calls early end to US selling

When Pfizer’s US Enbrel sales force gives way to Amgen’s in July, reps risk layoff if they don’t get picked up by Amgen or re-assigned to Pfizer’s new JAK inhibitor. The news that Pfizer was turning ...
pharmaphorum

Mylan to market Lupin's Enbrel biosimilar outside US

Mylan has joined with India’s Lupin to market a biosimilar of Amgen/Pfizer’s inflammatory diseases blockbuster Enbrel (etanercept) in ex-US markets. Approved in a range of diseases including ...
The Greeley Tribune

Colorado moves to cap price of arthritis drug Enbrel in first-in-the-nation action by state affordability board

A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...
FiercePharma

Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness

Drug pricing may be a secretive affair in the U.S., but every quarter, earnings reports offer a peek behind the curtain. This time around, the numbers show pricing power dwindling away in some ...
FiercePharma

Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...
The Motley Fool

Amgen's Enbrel Patents to Be Upheld Through 2029

An appeals court ruling means biosimilar competition won't affect U.S. Enbrel sales for a long time. Enbrel is a tumor necrosis factor (TNF) inhibitor that earned its first FDA approval all the way ...